Gene Expression Profiling of H9c2 Cells Subjected to H2O2-Induced Apoptosis with/without AF-HF001

Biological and Pharmaceutical Bulletin

Volumn 39, Issue 2, 2016, Pages 207-214

  Wang, Guping ^a   Tang, Chunlei ^a   Yan, Guijun ^b   Feng, Bainian ^a  

^a JIANGNAN UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

AF HF001; Apoptosis; DNA microarray; H9c2 cell; Oxidative damage

Indexed keywords

AF HF 001; CARDIOVASCULAR AGENT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; AF-HF001; HYDRAZONE DERIVATIVE; HYDROGEN PEROXIDE; NAPHTHOL DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; IN VITRO STUDY; MICROARRAY ANALYSIS; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; CARDIAC MUSCLE CELL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DNA MICROARRAY; DRUG EFFECTS; METABOLISM;

ANIMALS; APOPTOSIS; CARDIOVASCULAR AGENTS; CELL LINE; HYDRAZONES; HYDROGEN PEROXIDE; MOLECULAR STRUCTURE; MYOCYTES, CARDIAC; NAPHTHOLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES;

EID: 84958970419     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b15-00601     Document Type: Article

References (27)

1. Tang C, Xie D, Feng B. Zebrafish as a new model for phenotypebased screening of positive inotropic agents. Chem. Biol. Drug Des., 85, 253-258 (2015).
2. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med., 335, 1182-1189 (1996).
3. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Dal Bello B, Semigran MJ, Bielsa-Masdeu A, Dec GW, Israels S, Ballester M, Virmani R, Saxena S, Kharbanda S. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc. Natl. Acad. Sci. U.S.A., 96, 8144-8149 (1999).
4. Wang L, Huang H, Fan Y, Kong B, Hu H, Hu K, Guo J, Mei Y, Liu WL. Effects of downregulation of microRNA-181a on H2O2-induced H9c2 cell apoptosis via the mitochondrial apoptotic pathway. Oxid. Med. Cell. Longev., 2014, 960362 (2014).
5. Wei SS, Liao XX, Yang CT, Lin JY, Yang ZL, Lan AP, Huang X, Wang LC, Chen PX, Feng JQ. Reactive oxygen species scavenger protects cardiac cells against injuries induced by chemical hypoxia. Nan Fang Yi Ke Da Xue Bao, 29, 1977-1981 (2009).
6. Mollova M, Bersell K, Walsh S, Savla J, Das LT, Park SY, Silberstein LE, Dos Remedios CG, Graham D, Colan S, Kühn B. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc. Natl. Acad. Sci. U.S.A., 110, 1446-1451 (2013).
7. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J. Evidence for cardiomyocyte renewal in humans. Science, 324, 98-102 (2009).
8. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem., 278, 8516-8525 (2003).
9. Jacquemin G, Margiotta D, Kasahara A, Bassoy EY, Walch M, Thiery J, Lieberman J, Martinvalet D. Granzyme B-induced mitochondrial ROS are required for apoptosis. Cell Death Differ., 22, 862-874 (2015).
10. Massoz S, Larosa V, Plancke C, Lapaille M, Bailleul B, Pirotte D, Radoux M, Leprince P, Coosemans N, Matagne RF, Remacle C, Cardol P. Inactivation of genes coding for mitochondrial Nd7 and Nd9 complex I subunits in Chlamydomonas reinhardtii. Impact of complex I loss on respiration and energetic metabolism. Mitochondrion, 19 (Pt B), 365-374 (2014).
11. Hershberger RE, Norton N, Morales A, Li D, Siegfried JD, Gonzalez-Quintana J. Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ. Cardiovasc. Genet., 3, 155-161 (2010).
12. Singer JM, Shaw JM. Mdm20 protein functions with Nat3 protein to acetylate Tpm1 protein and regulate tropomyosin-actin interactions in budding yeast. Proc. Natl. Acad. Sci. U.S.A., 100, 7644-7649 (2003).
13. Rossi AC, Mammucari C, Argentini C, Reggiani C, Schiaffino S. Two novel/ancient myosins in mammalian skeletal muscles: MYH14/7b and MYH15 are expressed in extraocular muscles and muscle spindles. J. Physiol., 588, 353-364 (2010).
14. Choi BO, Kang SH, Hyun YS, Kanwal S, Park SW, Koo H, Kim SB, Choi YC, Yoo JH, Kim JW, Park KD, Choi KG, Kim SJ, Zuchner S, Chung KW. A complex phenotype of peripheral neuropathy, myopathy, hoarseness, and hearing loss is linked to an autosomal dominant mutation in MYH14. Hum. Mutat., 32, 669-677 (2011).
15. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc. Res., 37, 279-289 (1998).
16. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ. Res., 92, 827-839 (2003).
17. Takawale A, Fan D, Basu R, Shen M, Parajuli N, Wang W, Wang X, Oudit GY, Kassiri Z. Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4. Circ. Heart Fail., 7, 652-662 (2014).
18. Chaturvedi P, Kalani A, Familtseva A, Kamat PK, Metreveli N, Tyagi SC. Cardiac tissue inhibitor of matrix metalloprotease 4 dictates cardiomyocyte contractility and differentiation of embryonic stem cells into cardiomyocytes: Road to therapy. Int. J. Cardiol., 184, 350-363 (2015).
19. Rebocho AP, Marais R. ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers. Oncogene, 32, 3207-3212 (2013).
20. Muslin AJ. Role of raf proteins in cardiac hypertrophy and cardiomyocyte survival. Trends Cardiovasc. Med., 15, 225-229 (2005).
21. Okamura D, Mochizuki K, Taniguchi H, Tokitake Y, Ikeda M, Yamada Y, Tournier C, Yamaguchi S, Tada T, Scholer HR, Matsui Y. REST and its downstream molecule Mek5 regulate survival of primordial germ cells. Dev. Biol., 372, 190-202 (2012).
22. Takahashi N, Saito Y, Kuwahara K, Harada M, Tanimoto K, Nakagawa Y, Kawakami R, Nakanishi M, Yasuno S, Usami S, Yoshimura A, Nakao K. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. J. Mol. Cell. Cardiol., 38, 185-192 (2005).
23. Park JE, Park BC, Kim HA, Song M, Park SG, Lee DH, Kim HJ, Choi HK, Kim JT, Cho S. Positive regulation of apoptosis signalregulating kinase 1 by dual-specificity phosphatase 13A. Cell. Mol. Life Sci., 67, 2619-2629 (2010).
24. Gupta S, Knowlton AA. HSP60, Bax, apoptosis and the heart. J. Cell. Mol. Med., 9, 51-58 (2005).
25. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, Gurbuxani S, Arrigo AP, Kroemer G, Solary E, Garrido C. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell Biol., 2, 645-652 (2000).
26. Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ., 6, 99-104 (1999).
27. Changchien JJ, Chen YJ, Huang CH, Cheng TL, Lin SR, Chang LS. Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression. Toxicol. Appl. Pharmacol., 284, 33-41 (2015).